A Third Anti-Sars-Cov2 Mrna Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy And/or Low Immunoglobulin Level in CLL/Lymphoma PatientsMaureen Chbat,Milena Kohn,Fatiha Merabet,Anne-Laure Roupie,Naelle Lombion,Amina Guemriche,Stephanie Marque-Juillet,Victoria Raggueneau,Jennifer Osman,Marc Spentchian,Marc Delord,Sophie Rigaudeau,Caroline BessonBlood(2021)引用 11|浏览28暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要